Leading bariatric specialists Dr. Todkar, Dr. Dukkipati & Dr. Garg share crucial insights on managing India's dual health crisis through early intervention & lifestyle changes. Act now for better health!
Delhi government announces nursery admission schedule for 2026-27. Forms available from Dec 4, first merit list on Jan 23. Check age criteria and important dates here.
Childhood obesity in India surges from 3-4% to 8-9%, driven by lifestyle changes and mental health factors. Dr. Atul Peters reveals how families can reverse this alarming trend through simple changes.
Karnataka government implements High Court directive requiring all guest faculty in government colleges to meet UGC eligibility standards. Learn how this impacts education quality.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
A new report reveals a sharp 5-fold increase in obesity in India over 30 years, affecting 1 in 4 adults. Learn about the health risks and what it means for the nation.
New Lancet study reveals 25% of Indians face obesity, costing economy ₹29,000 crore annually. Urgent public health action needed to address this growing crisis.
New OSSI survey reveals insurance barriers prevent timely obesity treatment in India. Learn how policy gaps affect patient care and what needs to change.
Delhi announces private school admission schedule for 2026-27. Forms from Dec 4, first list on Jan 23. Key dates and transparent process details inside.
Understand how banks determine pre-approved personal loan eligibility. Learn about credit score requirements, income criteria, and how to increase your chances of approval.
PGI Chandigarh warns of a sharp increase in Type 2 diabetes among children and young adults, driven by junk food and sedentary lifestyles. Learn how to prevent it.
India's Supreme Court directs Centre to create uniform organ transplantation rules, addressing gender and caste bias while establishing nationwide donor criteria. Read how this landmark decision will transform healthcare.
Lancet study reveals India's ultra-processed food epidemic with retail sales skyrocketing 40-fold since 2006, driving obesity and diabetes crisis among youth. Experts demand urgent policy reforms.
Central government denies metro rail networks for Madurai and Coimbatore, citing 2011 census data despite current population exceeding 20 lakh. Read the full analysis.
Discover the top 6 lifestyle diseases affecting Indians, their causes, symptoms, and preventive measures. Learn how to protect your health today!
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Lars Rebien Sorensen returns as Novo Nordisk chairman after board shakeup. The move follows Pfizer's $10B Metsera acquisition, intensifying obesity drug competition.
Assam Police reports significant fitness improvement with only 2.06% of 73,317 personnel classified as obese in annual BMI tests. Discover how the force is getting leaner and mission-ready.
A 16-year-old Mumbai student reversed his Type 2 diabetes risk factors. Discover how an endocrinologist's plan involving diet, exercise, and family support led to a 7 kg weight loss and improved HbA1c levels in six months.
Arjun Kapoor speaks candidly about his mental health journey, starting therapy during lockdown, and overcoming obesity. Read his powerful message on strength.
A 36-year-old Chinese man died days after gastric bypass surgery he hoped would help him impress his girlfriend's parents. The tragedy sparks debate about weight-loss surgery risks.
Lancet study shows child hypertension doubled 2000-2020. 114 million affected globally. Obesity, poor diet, sedentary lifestyles identified as key triggers. Learn prevention strategies.
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Trump administration secures obesity drug price cuts with Eli Lilly and Novo Nordisk. Medicare coverage expansion opens 30 million patient market starting April 2026. Read analysis.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Medical experts warn of alarming surge in obesity and heart attacks among young Indians. Discover how adopting Blue Zone lifestyle principles could reverse this dangerous trend.
Discover why revolutionary weight-loss drugs aren't magic bullets for India's obesity crisis. Learn about limitations, costs, and sustainable solutions.
New data exposes America's weight divide: Discover which states top the obesity charts and which maintain healthier lifestyles in this comprehensive health analysis.
Former US President Donald Trump is negotiating with Novo Nordisk to offer weight-loss drugs at just $149. Discover how this could revolutionize affordable healthcare and impact India's growing obesity crisis.